Researchers develop regenerative, safe therapeutic for Alzheimer’s disease

University of Arizona researchers have developed a new therapy for Alzheimer’s disease designed to restore cognitive function in early-stage patients. The therapy is now proceeding through a Phase 2b clinical trial. Phase 2b trials involve rigorous testing for efficacy in groups of 100 to 300 patients. The team, led by Roberta Diaz Brinton, director of […]

Continue Reading